In a world of data center discussions, AI slop and fears of AI destroying humanity, always encouraging when AI is used for something that could benefit mankind. OpenAI just demonstrated how thousands of AI agents could help tackle that same kind of work in 32 minutes.

In a new study announced Wednesday, OpenAI teamed up with PerturbAI and Scripps Research to analyze experimental data from millions of mouse brain cells. Instead of relying on a single AI model, the researchers deployed thousands of agents simultaneously, each investigating how changes to a particular gene affected brain cells.

The results included potential new clues about neurological diseases, including a possible connection between cholesterol regulation and neurodegeneration. The agents also identified unexpected differences between two genes associated with a condition that affects brain development and function.

To be clear, AI has not discovered a cure for Alzheimer's or Parkinson's disease. The findings are early research leads that scientists still need to test. However, the study offers a glimpse of how AI could accelerate medical research by helping scientists find connections buried in enormous amounts of existing data.

The researchers used GPT-Rosalind, OpenAI's specialized AI model for life sciences, to examine a dataset showing what happens when different genes are disrupted in mouse brain cells.

Each agent focused on a specific genetic change, studied how cells responded and searched scientific literature for possible explanations. The findings were then combined into what the researchers call a "reasoning atlas," connecting genes, cellular changes and existing scientific knowledge.

Source link